Showing results (131-140 of 990) with videos related to
Sort By:
Pageof 99
Pharmacy World & Science : PWS|November 17, 2007
Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadoneNathalie Colombini, Riad Elias, Muriel Busuttil, et al.Pharmacy World & Science : PWS|November 22, 2007
Pharmacist domiciliary visiting in England: identifying the characteristics associated with continuationDebi Bhattacharya, David J Wright, John R PurvisPharmacy World & Science : PWS|June 25, 2008
Osteoporosis after combined use of a neuroleptic and antidepressantsGert Laekeman, Lieven Zwaenepoel, Johan Reyntens, et al.Pharmacy World & Science : PWS|November 11, 2008
Facilitators for practice change in Spanish community pharmacyMiguel A Gastelurrutia, S I Charlie Benrimoj, Carla C Castrillon, et al.Pharmacy World & Science : PWS|November 5, 2008
Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsisInge Hagen, Knut ØymarPharmacy World & Science : PWS|September 25, 2007
Scottish pharmacists' views and attitudes towards continuing professional developmentAilsa Power, B Julienne Johnson, H Lesley Diack, et al.Pharmacy World & Science : PWS|August 28, 2007
Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitusMajidreza Kamyar, B Julienne Johnson, John J McAnaw, et al.Pharmacy World & Science : PWS|August 28, 2007
Measuring health-related quality of life in drug clinical trials: is it given due importance?Ramón San Miguel, Ana María López-González, Eduardo Sanchez-Iriso, et al.Pharmacy World & Science : PWS|September 21, 2007
Recall of drug utilization depends on subtle structural questionnaire characteristicsNuno Lunet, Joana Bastos, Florência Cumaio, et al.Pharmacy World & Science : PWS|April 14, 2007
Do Finnish women using hormone replacement therapy need more information about risksMiia J Tiihonen, Anna-Mari Heikkinen, Riitta S AhonenPageof 99